Hypoxia-inducible factor-1α: A promising therapeutic target for vasculopathy in diabetic retinopathy

Hui-Yao Li,Yue Yuan,Yu-Hong Fu,Ying Wang,Xin-Yuan Gao
DOI: https://doi.org/10.1016/j.phrs.2020.104924
IF: 10.334
2020-09-01
Pharmacological Research
Abstract:<p>Diabetic retinopathy (DR) is a serious condition that can cause blindness in diabetic patients. It is a neurovascular disease, but the pathogenesis leading to the onset of this disease is still not completely understood. However, hypoxia with subsequent neovascularization is a characteristic phenomenon observed with DR. Cellular response to hypoxia is mediated by the transcriptional regulator hypoxia-inducible factor (HIF). Long-term research has shown that one isotype of HIF, HIF-1α, may play a pivotal role under hypoxic conditions, and an increasing number of studies have shown that HIF-1α and its target genes contribute to retinal neovascularization. Therefore, targeting HIF-1α may lead to more effective DR treatments. This review describes the possible mechanisms of HIF-1α in neovascularization of DR. Furthermore, various inhibitors of HIF-1α that may have viable potential in the treatment of DR are also discussed.</p>
pharmacology & pharmacy
What problem does this paper attempt to address?